{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:milrinone",
  "owner": "cardio",
  "kind": "drug",
  "slug": "milrinone",
  "name": "Milrinone",
  "aliases": [
    "Milrinone lactate"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Milrinone is a medicine given into a vein. A US label for milrinone lactate injection lists it for short-term treatment of patients with acute decompensated heart failure. The label describes it as a positive inotrope, a medicine that strengthens the heartbeat, and a vasodilator, which widens blood vessels. The label says patients receiving it \"should be observed closely with appropriate electrocardiographic equipment\" and that treatment for \"potential cardiac events, which may include life threatening ventricular arrhythmias, must be available.\" It also says \"There is no experience in controlled trials with infusions of milrinone for periods exceeding 48 hours.\"",
  "summary_technical": "RxNorm ingredient 52769; UNII 9K8XR81MO8 is the UNII of the salt, milrinone lactate, that the label gives, so it is a broad match; MeSH descriptor D020105 (Milrinone). US drug-label class: Phosphodiesterase 3 Inhibitor (established pharmacologic class, RxClass). The MeSH scope note says it inhibits cAMP phosphodiesterase type 3 activity in myocardium and vascular smooth muscle. The label read is the Hikma Pharmaceuticals USA label for milrinone lactate (vial and premixed dextrose forms), application ANDA077966, effective 2025-05-08 in openFDA; openFDA lists many other milrinone labels, which were not read. This page records the label indication and the class only: no trial result and no dose is given. The parent class page (inotropes and vasopressors) is not written yet, so the page has no parent link.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-08",
  "last_evidence_check": "2026-11-08",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "rxnorm",
      "value": "52769",
      "normalized_value": "52769",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "unii",
      "value": "9K8XR81MO8",
      "normalized_value": "9K8XR81MO8",
      "match": "broad",
      "version": null,
      "label": "Milrinone lactate",
      "from_source": false
    },
    {
      "scheme": "mesh",
      "value": "D020105",
      "normalized_value": "D020105",
      "match": "exact",
      "version": "MeSH linked-data descriptor, read 2026-11-08",
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "heart"
      ],
      "condition-area": [
        "heart-failure",
        "acute-care-and-long-term-living"
      ]
    }
  },
  "payload": {
    "level": "substance",
    "mechanism": "The MeSH scope note says milrinone inhibits cAMP phosphodiesterase type 3 activity in heart muscle and in the smooth muscle of blood vessels. The label calls it a positive inotrope and vasodilator."
  },
  "content_digest": "88d6d1b68f556082ab245dfcc223ff5470d15f20218759cf42343f51c7078763",
  "review": {
    "content_digest": "88d6d1b68f556082ab245dfcc223ff5470d15f20218759cf42343f51c7078763",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-milrinone-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:milrinone",
      "category": "descriptive",
      "statement": "The US label of milrinone lactate injection (Hikma Pharmaceuticals, abbreviated application ANDA077966; version dated 8 May 2025 in openFDA) lists the medicine for short-term intravenous treatment of patients with acute decompensated heart failure. The same section says that patients receiving milrinone \"should be observed closely with appropriate electrocardiographic equipment\" and that the facility for immediate treatment of \"potential cardiac events, which may include life threatening ventricular arrhythmias, must be available.\" It also says \"There is no experience in controlled trials with infusions of milrinone for periods exceeding 48 hours.\" The label describes the medicine as a positive inotrope and vasodilator with little chronotropic activity.",
      "context": {
        "id": "cardio:ctx-fda-milrinone-label-us",
        "label": "Patients for whom the US milrinone lactate injection label lists short-term intravenous treatment: acute decompensated heart failure",
        "recipient": "unknown",
        "population": "Patients with acute decompensated heart failure, as the indications section describes them; the sentence does not name an age group.",
        "care_setting": "Intravenous medicine used with close observation and electrocardiographic equipment, as the indications section describes",
        "geography": "United States (label of the US Food and Drug Administration)",
        "life_stage_note": "Not stated in the indication sentence",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Patients with acute decompensated heart failure"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what one generic label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. Only the indications section and the first sentence of the pharmacology section were read; contraindications, warnings, doses, interactions and adverse reactions were not recorded. The label covers both the vial and the premixed dextrose product. openFDA says its data are unvalidated and not to be relied on for decisions about medical care. openFDA lists many other milrinone labels from other makers, which were not read.",
      "editorial_state": "draft",
      "checked_at": "2026-11-08",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].openfda.application_number[0]",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682-2026-11-08",
            "retrieved_at": "2026-11-08T20:38:19Z",
            "content_hash": "852c38e8f63fbe1a379e8a263ba3d7f27b310b0a16f014d7f2394b6ae1974a4d",
            "source_effective_date": "2025-05-08",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682",
            "source_type": "label",
            "title": "openFDA drug label record: Milrinone Lactate (Hikma, ANDA077966)",
            "canonical_url": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88f78780-399f-4780-be19-205739db1682",
            "identifiers": [
              {
                "scheme": "spl-set-id",
                "value": "88f78780-399f-4780-be19-205739db1682",
                "normalized_value": "88f78780-399f-4780-be19-205739db1682",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA drug label endpoint)",
            "edition": "openFDA drug label record, label effective 20250508, dataset last updated 2026-11-06.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). Only short passages are quoted. The raw record is committed at research/snapshots/w431-openfda-label-88f78780-399f-4780-be19-205739db1682.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].effective_time",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682-2026-11-08",
            "retrieved_at": "2026-11-08T20:38:19Z",
            "content_hash": "852c38e8f63fbe1a379e8a263ba3d7f27b310b0a16f014d7f2394b6ae1974a4d",
            "source_effective_date": "2025-05-08",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682",
            "source_type": "label",
            "title": "openFDA drug label record: Milrinone Lactate (Hikma, ANDA077966)",
            "canonical_url": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88f78780-399f-4780-be19-205739db1682",
            "identifiers": [
              {
                "scheme": "spl-set-id",
                "value": "88f78780-399f-4780-be19-205739db1682",
                "normalized_value": "88f78780-399f-4780-be19-205739db1682",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA drug label endpoint)",
            "edition": "openFDA drug label record, label effective 20250508, dataset last updated 2026-11-06.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). Only short passages are quoted. The raw record is committed at research/snapshots/w431-openfda-label-88f78780-399f-4780-be19-205739db1682.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].openfda.brand_name[0]",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682-2026-11-08",
            "retrieved_at": "2026-11-08T20:38:19Z",
            "content_hash": "852c38e8f63fbe1a379e8a263ba3d7f27b310b0a16f014d7f2394b6ae1974a4d",
            "source_effective_date": "2025-05-08",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682",
            "source_type": "label",
            "title": "openFDA drug label record: Milrinone Lactate (Hikma, ANDA077966)",
            "canonical_url": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88f78780-399f-4780-be19-205739db1682",
            "identifiers": [
              {
                "scheme": "spl-set-id",
                "value": "88f78780-399f-4780-be19-205739db1682",
                "normalized_value": "88f78780-399f-4780-be19-205739db1682",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA drug label endpoint)",
            "edition": "openFDA drug label record, label effective 20250508, dataset last updated 2026-11-06.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). Only short passages are quoted. The raw record is committed at research/snapshots/w431-openfda-label-88f78780-399f-4780-be19-205739db1682.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1 sentence 1",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682-2026-11-08",
            "retrieved_at": "2026-11-08T20:38:19Z",
            "content_hash": "852c38e8f63fbe1a379e8a263ba3d7f27b310b0a16f014d7f2394b6ae1974a4d",
            "source_effective_date": "2025-05-08",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682",
            "source_type": "label",
            "title": "openFDA drug label record: Milrinone Lactate (Hikma, ANDA077966)",
            "canonical_url": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88f78780-399f-4780-be19-205739db1682",
            "identifiers": [
              {
                "scheme": "spl-set-id",
                "value": "88f78780-399f-4780-be19-205739db1682",
                "normalized_value": "88f78780-399f-4780-be19-205739db1682",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA drug label endpoint)",
            "edition": "openFDA drug label record, label effective 20250508, dataset last updated 2026-11-06.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). Only short passages are quoted. The raw record is committed at research/snapshots/w431-openfda-label-88f78780-399f-4780-be19-205739db1682.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1 sentence 2",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682-2026-11-08",
            "retrieved_at": "2026-11-08T20:38:19Z",
            "content_hash": "852c38e8f63fbe1a379e8a263ba3d7f27b310b0a16f014d7f2394b6ae1974a4d",
            "source_effective_date": "2025-05-08",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682",
            "source_type": "label",
            "title": "openFDA drug label record: Milrinone Lactate (Hikma, ANDA077966)",
            "canonical_url": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88f78780-399f-4780-be19-205739db1682",
            "identifiers": [
              {
                "scheme": "spl-set-id",
                "value": "88f78780-399f-4780-be19-205739db1682",
                "normalized_value": "88f78780-399f-4780-be19-205739db1682",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA drug label endpoint)",
            "edition": "openFDA drug label record, label effective 20250508, dataset last updated 2026-11-06.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). Only short passages are quoted. The raw record is committed at research/snapshots/w431-openfda-label-88f78780-399f-4780-be19-205739db1682.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1 sentence 3",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682-2026-11-08",
            "retrieved_at": "2026-11-08T20:38:19Z",
            "content_hash": "852c38e8f63fbe1a379e8a263ba3d7f27b310b0a16f014d7f2394b6ae1974a4d",
            "source_effective_date": "2025-05-08",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682",
            "source_type": "label",
            "title": "openFDA drug label record: Milrinone Lactate (Hikma, ANDA077966)",
            "canonical_url": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88f78780-399f-4780-be19-205739db1682",
            "identifiers": [
              {
                "scheme": "spl-set-id",
                "value": "88f78780-399f-4780-be19-205739db1682",
                "normalized_value": "88f78780-399f-4780-be19-205739db1682",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA drug label endpoint)",
            "edition": "openFDA drug label record, label effective 20250508, dataset last updated 2026-11-06.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). Only short passages are quoted. The raw record is committed at research/snapshots/w431-openfda-label-88f78780-399f-4780-be19-205739db1682.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1 sentence 5",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682-2026-11-08",
            "retrieved_at": "2026-11-08T20:38:19Z",
            "content_hash": "852c38e8f63fbe1a379e8a263ba3d7f27b310b0a16f014d7f2394b6ae1974a4d",
            "source_effective_date": "2025-05-08",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682",
            "source_type": "label",
            "title": "openFDA drug label record: Milrinone Lactate (Hikma, ANDA077966)",
            "canonical_url": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88f78780-399f-4780-be19-205739db1682",
            "identifiers": [
              {
                "scheme": "spl-set-id",
                "value": "88f78780-399f-4780-be19-205739db1682",
                "normalized_value": "88f78780-399f-4780-be19-205739db1682",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA drug label endpoint)",
            "edition": "openFDA drug label record, label effective 20250508, dataset last updated 2026-11-06.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). Only short passages are quoted. The raw record is committed at research/snapshots/w431-openfda-label-88f78780-399f-4780-be19-205739db1682.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].clinical_pharmacology[0], 1",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682-2026-11-08",
            "retrieved_at": "2026-11-08T20:38:19Z",
            "content_hash": "852c38e8f63fbe1a379e8a263ba3d7f27b310b0a16f014d7f2394b6ae1974a4d",
            "source_effective_date": "2025-05-08",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682",
            "source_type": "label",
            "title": "openFDA drug label record: Milrinone Lactate (Hikma, ANDA077966)",
            "canonical_url": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88f78780-399f-4780-be19-205739db1682",
            "identifiers": [
              {
                "scheme": "spl-set-id",
                "value": "88f78780-399f-4780-be19-205739db1682",
                "normalized_value": "88f78780-399f-4780-be19-205739db1682",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA drug label endpoint)",
            "edition": "openFDA drug label record, label effective 20250508, dataset last updated 2026-11-06.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). Only short passages are quoted. The raw record is committed at research/snapshots/w431-openfda-label-88f78780-399f-4780-be19-205739db1682.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "cb4701d57ca40fdacf58580a3728fabcf230281c64d88f14cb15e6e582c63c9f",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-milrinone-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "evaluated_for",
        "label": "The US label lists short-term intravenous treatment of acute decompensated heart failure",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:heart-failure",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-milrinone-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Filed under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "The US label calls milrinone a positive inotrope and vasodilator",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:inotropes-and-vasopressors",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:openfda-label-88f78780-399f-4780-be19-205739db1682-2026-11-08",
          "locator": "results[0].clinical_pharmacology[0]"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct03207165",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03207165-2020-06-30",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct05267886",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct05267886-2026-05-01",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda019436",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda019436-2007-10-30",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda020343",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda020343-2007-10-30",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/milrinone/",
  "context_path": "api/v1/context/cardio--milrinone.md"
}
